The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
IRF7: activation, regulation, modification and function
Open accessAbstract
Interferon regulatory factor 7 (IRF7) was originally identified in the context of Epstein–Barr virus (EBV) infection, and has since emerged as the crucial regulator of type I interferons (IFNs) against pathogenic infections, which activate IRF7 by triggering signaling cascades from pathogen recognition receptors (PRRs) that recognize pathogenic nucleic acids. Moreover, IRF7 is a multifunctional transcription factor, underscored by the fact that it is associated with EBV latency, in which IRF7 is induced as well as activated by the EBV principal oncoprotein latent membrane protein-1 (LMP1). Aberrant production of type I IFNs is associated with many types of diseases such as cancers and autoimmune disorders. Thus, tight regulation of IRF7 expression and activity is imperative in dictating appropriate type I IFN production for normal IFN-mediated physiological functions. Posttranslational modifications have important roles in regulation of IRF7 activity, exemplified by phosphorylation, which is indicative of its activation. Furthermore, mounting evidence has shed light on the importance of regulatory ubiquitination in activation of IRF7. Albeit these exciting findings have been made in the past decade since its discovery, many questions related to IRF7 remain to be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–239 of 239
Zhang, L., Zhang, J., Lambert, Q. T., Der, C. J., Valle, L. D., Miklossy, J., Khalili, K., Zhou, Y., & Pagano, J. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12987-12995.2004 · Cited by 66
Self-citationStimulation of IRF-7 Gene Expression by Tumor Necrosis Factor α
Lu, R., Moore, P. A., & Pitha, P. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111440200 · Cited by 65
Regulation of IRF7 through cell type-specific protein stability
Prakash, A., & Levy, D. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.122 · Cited by 65
Zhang, L., & Pagano, J. S. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.341-350.2001 · Cited by 65
Self-citationPietilä, T. E., Veckman, V., Lehtonen, A., Lin, R., Hiscott, J. B., & Julkunen, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.253 · Cited by 64
Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis
Park, J., Kim, K., Lee, E., Seo, Y.-J., Lim, S., Park, K., Rho, S. B., Lee, S., & Lee, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609852104 · Cited by 64
BRCA1 Regulates the Interferon γ-mediated Apoptotic Response
Andrews, H. N., Mullan, P. B., McWilliams, S., Šebelová, Š., Quinn, J. E., Gilmore, P. M., McCabe, N., Pace, A. J., Koller, B. H., Johnston, P. G., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201316200 · Cited by 64
Masumi, A., & Ozato, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101707200 · Cited by 62
Li, Q., Tang, L., Roberts, P. C., Kraniak, J. M., Fridman, A. L., Kulaeva, O. I., Tehrani, O. S., & Tainsky, M. A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0114 · Cited by 62
Park, B.-K. (2001) · Immune Network · doi:10.4110/in.2001.1.2.109 · Cited by 60
Interferon Regulatory Factor-2 Regulates Cell Growth through Its Acetylation
Masumi, A., Yamakawa, Y., Fukazawa, H., Ozato, K., & Komuro, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213037200 · Cited by 60
Rahadiani, N., Takakuwa, T., Tresnasari, K., Morii, E., & Aozasa, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.007 · Cited by 60
Zhang, L., & Pagano, J. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3216 · Cited by 58
Self-citationZhu, F. X., Sathish, N., & Yuan, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010573 · Cited by 57
Huang, Y., Walstrom, A., Zhang, L., Zhao, Y. L., Cui, M., Ye, L., & Zheng, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005397 · Cited by 53
Pagano, J. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmp020056 · Cited by 49
Self-citationSong, Y., Izumi, K. M., Shinners, N. P., Gewurz, B. E., & Kieff, E. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809933105 · Cited by 49
Kim, T. K., Kim, T. I., Kim, T. Y., Lee, W. G., & Yim, J. (2000) · PubMed · Cited by 48
Xu, D., Brumm, K., & Zhang, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511884200 · Cited by 46
Ning, S., Huye, L. E., & Pagano, J. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11671-11676.2005 · Cited by 46
Self-citationXiong, H., Li, H., Kong, H. J., Chen, Y., Zhao, J., Xiong, S., Huang, B., Gu, H., Mayer, L., Ozato, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414296200 · Cited by 46
Differential regulation of IKKα-mediated activation of IRF3/7 by NIK
Wang, R., Zhang, M., Li, Y., Diao, F., Chen, D., Zhai, Z., & Shu, H. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.034 · Cited by 38
Pettersson, S., Kelleher, M., Pion, E., Wallace, M., & Ball, K. L. (2008) · Biochemical Journal · doi:10.1042/bj20082087 · Cited by 38
Okabe, Y., Kawane, K., & Nagata, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838559 · Cited by 34
Regulation of IRF2 transcriptional activity by its sumoylation
Han, K.-J., Jiang, L., & Shu, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.103 · Cited by 34
Targeting IRFs by ubiquitination: regulating antiviral responses
Higgs, R., & Jefferies, C. A. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360453 · Cited by 34
IRF‐7: New Role in the Regulation of Genes Involved in Adaptive Immunity
Sgarbanti, M., Marsili, G., Remoli, A. L., Orsatti, R., & Battistini, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.036 · Cited by 30
Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins
Tsuchida, T., Kawai, T., & Akira, S. (2009) · Cell Research · doi:10.1038/cr.2009.1 · Cited by 30
Functional Analysis of a Dominant Negative Mutation of Interferon Regulatory Factor 5
Yang, L., Zhao, T., Shi, X., Nakhaei, P., Wang, Y., Sun, Q., Hiscott, J. B., & Lin, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005500 · Cited by 27
Alizadeh, A. A., Bohen, S. P., Lossos, C., Martinez-Climent, J. A., Ramos, J. C., Cubedo, E., Harrington, W. J., & Lossos, I. S. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003728628 · Cited by 26
Buettner, N., Vogt, C., Martínez‐Sobrido, L., Weber, F., Waibler, Z., & Kochs, G. (2009) · Journal of General Virology · doi:10.1099/vir.0.015172-0 · Cited by 23
Regulation of Telomerase Activity by Interferon Regulatory Factors 4 and 8 in Immune Cells
Hrdličková, R., Nehyba, J., & Bose, H. R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00961-08 · Cited by 22
Another detour on the Toll road to the interferon antiviral response
Hiscott, J. B. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1104-1028 · Cited by 20
Zhao, Y. L., Xu, D., Jiang, Y., & Zhang, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009459 · Cited by 18
Aberrant expression of interferon regulatory factor 3 in human lung cancer
Tokunaga, T., Naruke, Y., Shigematsu, S., Kohno, T., Yasui, K., Ma, Y., Chua, K. J., Katayama, I., Nakamura, T., Hishikawa, Y., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.085 · Cited by 17
Pinheiro, R. F., Metze, K., Silva, M. R. R., & Chauffaille, M. D. L. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.03.008 · Cited by 16
SUMOylated IRF-1 shows oncogenic potential by mimicking IRF-2
Park, S.-M., Chae, M., Kim, B.-K., Seo, T., Jang, I., Choi, J.-S., Kim, I.-C., Lee, J.-H., & Park, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.166 · Cited by 13
Kusumoto, M., Fujii, Y., Tsukuda, Y., Ohira, T., Kyougoku, Y., Taniguchi, T., & Hakoshima, T. (1998) · Journal of Structural Biology · doi:10.1006/jsbi.1998.3970 · Cited by 10
Zhang, T., Wang, Y., Zhang, L., Liu, B., Xie, J., Wood, C. A., & Wang, J. (2010) · Journal of General Virology · doi:10.1099/vir.0.021816-0 · Cited by 9
Cited by
Macrophages as a therapeutic target to promote diabetic wound healing
Sharifiaghdam, M., Shaabani, E., Faridi-Majidi, R., De Smedt, S. C., Braeckmans, K., & Fraire, J. C. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.07.016 · Cited by 573
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Yin, X., Riva, L., Pu, Y., Martin-Sancho, L., Kanamune, J., Yamamoto, Y., Sakai, K., Gotoh, S., Miorin, L., De Jesus, P. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108628 · Cited by 383
Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5
Brisse, M., & Ly, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01586 · Cited by 365
Dawson, C. W., Port, R. J., & Young, L. S. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.004 · Cited by 355
Metadata
- Authors
- Ning, S., Pagano, J. S., & Barber, G. N.
- Venue
- Genes & Immunity
- Published
- 2011-04-14
- Volume
- 12
- Issue
- 6
- Pages
- 399-414
- ISSN
- 1466-4879 (ISSN-L)
- 1476-5470
- OpenAlex
- W2006406228
- Cited by
- 601
- References
- 239
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.